<PAGE>
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-KSB
(Mark One)
/X/ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the fiscal year ended November 30, 1996
OR
/ / TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
Commission File Number 0-21279
THERMACELL TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
FLORIDA 59-3223708
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
5419 PROVOST DRIVE 34690
NEW PORT RICHEY, FLORIDA (Zip Code)
(Address of principal executive offices)
Registrant's telephone number, including area code: (813) 938-3269
Securities registered pursuant to Section 12(b) of the Act: NONE
Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. YES /X/ NO / /
Indicate by check mark if disclosure of delinquent filers pursuant to Item
405 of Regulation S-K is not contained herein, and will not be contained, to the
best of Registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K. /X/
State issuer's revenues for its most recent fiscal year ........$615,845
Aggregate market value of the voting stock held by non-affiliates of the
registrant, based on the initial public offering price of $4.00 for 1,375,000
Units was $5,500,000. Common Stock outstanding of the closing of the initial
public offering on March 19, 1997 was 2,866,421 shares.
------------------------
DOCUMENTS INCORPORATED BY REFERENCE
None
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE>
THERMACELL TECHNOLOGIES, INC.
FORM 10-K
FOR THE YEAR ENDED DECEMBER 31, 1996
INDEX
-----
PART I PAGE
- ------ ----
Item 1 Business
Item 2 Properties
Item 3 Legal Proceedings
Item 4 Submission of Matters to a Vote of Security Holders
PART II
- -------
Item 5 Market of the Registrant's Securities and Related Stockholder
Matters
Item 6 Selected Financial Data
Item 7 Management's Discussion and Analysis of Financial Condition
and Results of Operations
Item 8 Financial Statements and Supplementary Data
Item 9 Disagreements on Accounting and Financial Disclosure
PART III
- --------
Item 10 Directors and Executive Officers of the Registrant
Item 11 Executive Compensation
Item 12 Security Ownership of Certain Beneficial Owners Management
Item 13 Certain Relationships and Related Transactions
PART IV
- -------
Item 14 Exhibits, Financial Statements, Schedules and Reports on Form
8-K
Signatures
<PAGE>
This Form 10-K contains forward looking information and statements within
the meaning of Section 27A of the Securities Act of 1933 and Section 21E of
the Securities Exchange Act of 1934. Actual results could differ materially
from those projected in the forward looking statements contained in this
Prospectus.
PART I
ITEM 1. BUSINESS.
GENERAL
The Company was incorporated in Florida in August 1993, for the purpose of
developing, manufacturing and marketing insulating materials and coatings using
partially evacuated glass microspheres (sometimes referred to as "shells"). The
process of evacuation removes air and other gases from the sphere, thereby
creating a vacuum. A shell is a very small glass sphere (generally the size of a
grain of salt) made by crushing glass particles. The insertion of shells into
various materials and products ("shell technology") can substantially improve
the thermal resistive characteristics of such materials and products resulting
in improved insulation ("R") values. The more a shell is evacuated, the higher
the thermal resistive characteristics of the product or material to which the
shells are added.
Management of the Company believes that there is a broad range of
applications for introduction in products of evacuated or partially evacuated
shells, the effect of which is improved energy efficiency of such products
because of the inherent insulating characteristics provided by the glass
spheres. The Company's strategy is to commercially exploit the use of its shell
technology to improve the "R" values of a number of products. In fiscal year
1995, the Company completed the development of its first product line which
consists of paints and coatings containing shells in order to reduce heat
transmission and improve the insulation values of the products. The products are
marketed under the ThermaCool-TM- label.
On November 30, 1995, the Company acquired the assets of C.F. Darling Paint
& Chemicals, Inc., a paint manufacturing company, located in New Port Richey,
Florida ("Darling Paint") for $251,016 in cash. The Company also assumed the
real estate lease for the Darling Paint Facility. The Company acquired these
assets and assumed this real estate lease so that it would have a facility to
produce and develop paints and coatings for its ThermaCool-TM- product line
which incorporate its shell technology. Prior to this acquisition, the Company
was required to purchase paints and coatings from independent paint and coating
manufacturers.
The Company's business strategy is to (i) expand the marketing and
distribution of ThermaCool-TM- paints and coatings (ii) develop and manufacture
the Company's own shells and (iii) expand the shell technology to other
products, such as drywall, gypsum board, home siding materials and space foam
insulation. Other markets may include refrigeration and cooling systems,
automotive and transportation applications and cups and thermoses. There is no
assurance that the Company will be successful in penetrating any markets for the
ThermaCool-TM- product lines, developing commercially viable manufacturing
techniques or addressing other markets.
BUSINESS STRATEGY
The Company's business strategy to become profitable by commercially
exploiting its shell technologies is dependent upon the successful
implementation of the following:
(i) EXPAND THE MARKETING AND DISTRIBUTION OF THERMACOOL-TM- PAINTS AND
COATINGS. The use of shells in paints and coatings is the Company's initial
attempt to commercially apply its shell technology. Although the ultimate
objective of the Company is to commercially exploit fully evacuated shells
in a variety of products, management believes that the use of partially
evacuated shells properly combined with paints and coatings can improve the
insulating properties of these products. Management believes that the
acquisition of the assets of Darling Paint combined with the proceeds of
this offering which are earmarked for expanding and improving the Company's
painting and coating capacities and implementing a marketing program will
enable the Company to generate revenues from the sale of its ThermaCool-TM-
painting and coating products.
The initial ThermaCool-TM- product is a roof coating material which
incorporates the partially evacuated microspheres into a roof coating
mixture which the Company is able to manufacture through the assets it
acquired from Darling Paint. This product can be used to coat new roofs as
well as on the top
1
<PAGE>
of existing tiles, shingles and flat roofs. The coating can also be applied
by manufacturers of concrete and ceramic tiles. The Company is also
marketing a ThermaCool-TM- exterior wall coating which it believes can also
reduce emissivity and thermal conductivity.
Coatings are characterized as a protective barrier that is applicable to
various surfaces for protection from the elements. Paint is characterized as
a product to change the color of a particular surface. By this definition,
some paints may be classified as coatings, such as a semi-gloss enamel,
while flat wall paint would not. The basic difference between a roof and a
wall coating is the viscosity or thickness of the product. A roof, being
less vertical than a wall, can accept a thicker coating without the product
running or sagging. A thicker coat for a roof is preferable due to its
exposure to the elements. The application of shell technology to the
Company's products is limited to the ThermaCool-TM- roof and exterior wall
coatings where the insulative and energy efficiency characteristics of the
product are most beneficial. To date, in excess of 90% of the Company's
sales of ThermaCool-TM- products relate to roof products. The Company has
not yet developed an interior paint using its ThermaCool-TM- process. There
is no assurance that the Company will be able to develop products other than
roof and exterior wall coatings utilizing its ThermaCool-TM- process.
(ii) DEVELOP AND MANUFACTURE THE COMPANY'S OWN SHELLS. The Company has
applied for a patent involving the production of insulating microspheres in
a manner which enables the evacuation of gases in the shells. Such
evacuation results in lower gas pressure within the shells which can reduce
thermal conductivity, thus providing improved insulation qualities. The
manufacturing procedure involves the formation of water vapor in the shells
and then the subsequent evacuation of the shells by heating the shells which
causes out-permeation of the water vapor. Other patents have been granted
relating to various processes to evacuate glass shells. To the best of
management's knowledge, no one has been able to develop a commercially
viable process for the production of fully evacuated glass shells, due to
among other factors, manufacturing and technical restraints. Currently, the
Company is aware of three large multinational companies which manufacture
shells. The essential difference between the manufacturing process for
partially evacuated shells as compared to substantially or fully evacuated
shells are the techniques employed to evacuate gases from the shell which
improve its thermal conductivity or insulating value. Management of the
Company believes that the facilities and equipment currently exist which the
Company can use to manufacture highly or partially evacuated shells. The
Company intends to utilize $1,700,000 of the offering proceeds to locate a
suitable production facility and to equip this facility with the necessary
machinery, tooling, furnaces, and other items necessary to manufacture
highly or partially evacuated shells. There is no assurance that the Company
will be successful in its efforts to manufacture shells.
(iii) EXPAND THE SHELL TECHNOLOGY TO OTHER PRODUCTS. Management of the
Company believes the potential exists to commercially exploit other markets
suitable for the Company's shell technologies. Since 1992, the Company's
founders have been investigating the possibility of using evacuated glass
microspheres in a variety of products. Management has identified
construction components such as drywall, gypsum board, home siding materials
and space foam insulation as potential markets. Other potential markets
include refrigeration and cooling systems, automotive and transportation
applications, cups and thermoses. There is no assurance the Company will be
successful in penetrating other markets. The Company will only be able to
achieve this strategy if it is able to manufacture its own highly or
partially evacuated shells on an economical basis.
SHELL TECHNOLOGY
The Company has the rights to certain patent applications relating to
evacuated shells. The first involves a technique for manufacturing insulating
microspheres in a manner which enables the evacuation of retained gases within
the shells. This evacuation results in low gas pressure within the shell which
can
2
<PAGE>
reduce the thermal conductivity, thus improving insulation qualities. Evacuated
shells are capable of forming vacuums which limits heat transfer. The use of
evacuated glass microspheres as an important component of improved insulation
and the use of a reflective layer within or outside of the shells has also been
referred to in prior patents. The Company's patent application describes a
procedure that which through the use of water vapor and heat combined with the
introduction of certain gases results in the evacuation or substantial
evacuation of the gases contained in the interior of the shells.
The Company's other patent application uses evacuated shells introduced into
a coating. Such coatings may be used for roofs, exterior paints, interior paints
and other uses. The addition of evacuated or substantially evacuated spheres
into a coating provides the following characteristics: (i) a reduction in
radiant heat transfer by use of reflective coatings, (ii) the reduction of heat
transfer between shells by restricting the transfer to point contact and (iii) a
reduction in the heat transfer across a shell by a use of a partial or full
vacuum. Although patent counsel to the Company believes that patent protection
is available for these inventions, there is no assurance that such patents will
be granted. Although management believes that the processes described in the
patent applications are grounded upon sound scientific principles and the
machinery and equipment are available to implement the production techniques
necessary to manufacture evacuated shells on a commercial basis, there is no
assurance the Company will be able to economically and profitably manufacture
evacuated shells or otherwise exploit these inventions. The ThermaCool-TM-
product line currently offered by the Company does not rely upon these
inventions because ThermaCool-TM- paintings and coatings use partially, rather
than fully or substantially evacuated shells.
MANUFACTURING FACILITIES AND TECHNIQUES
Management intends to use $1,700,000 of the offering proceeds from the
public offering to acquire a suitable production facility and to equip this
facility with the necessary machinery, tooling, furnaces and other items
necessary to manufacture evacuated shells. Management anticipates the Company
will lease this facility on a three to five year term and acquire the
equipment necessary to manufacture shells. Internal cost estimates prepared
by management indicate that the Company will require at least $5,000,000 for
the initial 24 months of operations to develop and operate its ThermaCool-TM-
production facility and shell manufacturing facility. Management anticipates
that revenues generated from the sale of ThermaCool-TM- products along with
the offering proceeds from the public offering allocated to these facilities
will be sufficient to absorb these anticipated production and operating
costs. These estimates are based solely upon management's prior experience
and no independent engineering or other outside consultants' data, has been
utilized to determine these amounts. If these estimates prove to be incorrect
or if the sale of ThermaCool-TM- products does not generate sufficient
revenues, the Company's ability to develop and operate these facilities will
be adversely affected.
The basic process for manufacturing glass shells involves heating glass and
then partially drying and crushing the glass composition. The glass composition
is then size separated for different applications. Glass shells are then formed
and blown at high temperatures with the use of heat in a vertical furnace. The
completed glass shells are then separated from the shell residue. Management is
aware of three other companies that currently manufacture glass shells. These
glass shells are primarily used as filler material for plastics and ceramics.
The unevacuated glass shells are used in such material because they provide an
improved "ball bearing" effect for better flow and as a low cost filler material
in compounding. The manufacturing techniques proposed by the Company would be
similar to those currently utilized to manufacture shells, except that the
Company would also employ procedures which evacuate or substantially evacuate
the shells in the final stages of the production process.
The Company currently produces its ThermaCool-TM- product line at the
Darling Paint facility it acquired in November 1995. The Company also continues
to sell general paint products using conventional grinding and mixing methods
with the exception of the addition of spheres acquired from other sources
3
<PAGE>
necessary to formulate ThermaCool-TM- products. The Darling Paint facility
currently accommodates production of 360,000 gallons per year. The current plant
facility is capable of producing up to $5,000,000 in gross product sales. There
is no assurance that the Company will generate such revenues. The Company
intends to utilize approximately $200,000 of the offering proceeds to automate
and retool the Darling Paint facility.
COMPETITION
The Company's ThermaCool-TM- products compete in the special purpose
coatings market which is an extremely competitive market principally composed of
large multinational companies which have significantly greater assets, working
capital and marketing personnel than the Company. Special purpose coatings are
similar to architectural coatings such as normal house paints but differ in that
they are formulated for special applications or environmental conditions, such
as extreme temperatures, chemicals or corrosive conditions. Major producers of
special purpose coatings include PPG Industries, DuPont, Sherwin-Williams, RPM,
Inc., Inmont, Courtaulds, PLC, Glidden, Azkon.V. and Valspar Corp. The U.S.
Bureau of Census values the special purpose coatings market at approximately $3
billion in 1995. The roofing, coating and industrial construction coating market
segment represents approximately 15% of the total "special purpose coatings"
market, or 28,000,000 gallons valued at approximately $454,000,000.
Management believes that the primary competitive factors in the special
coatings product segment are quality, ease of use, service, warranty,
availability and price. The cost per gallon of ThermaCool-TM- is at the high end
of the price spectrum for paints and coatings ($17.00 to $25.00 per gallon).
Although management believes that the improved insulating characteristics of
ThermaCool-TM- add significant value and justify the higher cost, there is no
assurance that the Company's products will be accepted because of the higher
cost. The Company will be competing with larger, better capitalized and
nationally recognized competitors. The Company's current supply sources of
shells could become competitors. The Company expects that if its products become
successful, competitors will be more likely to develop and introduce into the
market place comparable products and technologies. There is no assurance that
the Company will be able to compete in the special purpose coatings or other
markets.
MARKETING AND DISTRIBUTION
The Company intends to market its ThermaCool-TM- products to roofers,
painters, distributors and manufacturers of special purpose coatings. The
Company's initial target markets include industrial and residential
construction, maintenance, storage tanks and roof coatings. The Company intends
to place advertisements in trade journals for the plastics, glass and
construction industries. In addition, the Company intends to participate in
trade shows and intends to aggressively promote the energy saving
characteristics of its ThermaCool-TM- product lines.
Currently, management believes that contractors, who purchase from
distributors, will be the primary customers for the Company's products. The
Company also intends to solicit established contractor distribution centers
as a source of marketing its ThermaCool-TM- products. It is anticipated that
the Company will add between two to four marketing and sales personnel after
the closing of the public offering to implement its marketing strategy.
Management's strategy is to attract individuals that have significant
contacts in the special purpose coatings industry. There is no assurance that
the Company will be able to attract individuals or that such individuals will
be successful in their marketing efforts. Currently, the Company has a
limited sales staff which is concentrating on direct sales until such time as
the Company has adequate funds to expand its sales force.
The Company currently has a retail outlet in New Port Richey, Florida. The
Company intends to utilize a portion of the offering proceeds to open additional
retail outlets in the West Central Florida area. Such expansion may occur
through the acquisition of an existing retail outlet, such as Darling Paint or
the opening of a new retail store through the assumption of a lease of a former
paint and coatings retail outlet
4
<PAGE>
such as the Sarasota location. In addition to new retail outlets, the Company
plans to market directly to specialty industries such as the RV motor home
industry and manufacturing housing industry. The Company will also target chains
such as Home Depot and Builder's Square as point of sale distribution outlets
for its products. The Company believes that viable business opportunity,
franchising and distribution relationships with existing painting and coating
contractors are additional marketing and distribution strategies which can
expand the sale of the Company's products. The Company also believes that its
products may be distributed through private label arrangements with other
distributors. There is no assurance that any of these marketing or distribution
strategies will be successful.
NEW PRODUCT APPLICATIONS AND DEVELOPMENT.
The Company anticipates using $465,000 from the proceeds of the public
offering for the research and development of new products and applications
utilizing shell technologies beyond paintings and coatings. Management has
identified construction components such as drywall, gypsum board, home siding
materials and space foam insulation as potential markets. Other potential
markets include refrigeration and cooling systems, automotive transportation
applications and cups and thermoses. This research and development will
primarily focus on the techniques and procedures necessary to combine
evacuated shells into materials which can benefit from improved insulation
and "R" values. There is no assurance that the Company will be successful
developing any new applications for evacuated shells.
PRODUCT LIABILITY INSURANCE AND WARRANTIES
The Company currently has product liability insurance in force with limits
of $1,000,000 per occurrence and $2,000,000 aggregate limit. There is no
assurance the Company can maintain this coverage or that it will be adequate to
protect the Company.
The Company supplies the following warranties for its products: (1) All
ThermaCool-TM- products have eight year warranties; (2) #44000 Acrylic House
Paint has a nine year warranty; (3) #4000 Acrylic House Paint has a seven year
warranty; (4) #2400 Acrylic Latex House Paint has a five year warranty; (5)
#2200 100% Vinyl Acrylic House Paint has a five year warranty. No other
warranties are issued by the Company. All remedies as to warranty failures
require only replacement of the product.
ITEM 2. PROPERTIES.
PROPERTIES
The Company currently leases and occupies 18,000 sq. ft. of space in New
Port Richey, Florida which lease expires in 1998 where C.F. Darling formerly
operated. This real estate lease was assumed in connection with the November 30,
1995, agreement to acquire Darling Paint's assets. The Company did not acquire
any real property in connection with the Darling Paint acquisition. Rather, the
Company assumed the real estate lease for the Darling Paint facility. Current
payments are $2,800 per month. The facility consists of approximately 5,000
square feet of office and retail space with the balance being used for
warehousing and manufacturing. The prior owners of C.F. Darling Paint &
Chemicals, Inc. were Frank and Anita Darling, unrelated parties to the Company.
In January 1997, the Company vacated its 2,500 square foot executive
office in the Interstate Business Park at 8306 Laurel Fair Circle, Suite 240,
Tampa, Florida. This lease expires on October 31, 1998 and requires monthly
rent of approximately $3,000.00. In addition, the Company closed its
Sarasota, Florida retail location located at 4215 South Tamiami Trail,
Sarasota, Florida. Monthly lease payments were $4,000.00 and the lease
expires on April 30, 1999. The Company is currently negotiating with the
landlords for each of these properties to terminate these leases on mutually
agreeable terms. The landlord of the Sarasota location agreed to accelerate
the expiration date to February 28, 1997. As part of such arrangements, the
Company may reoccupy these premises. Management of the Company believes that
the proceeds generated from this offering will enable the Company to
negotiate acceptable lease termination provisions. Management further
believes that there are other suitable locations in the Tampa Bay area to
5
<PAGE>
locate its executive offices after the closing of this Offering and that there
are other suitable retail outlets in Sarasota, Florida and other areas to expand
its distribution capacity. The failure of the Company to negotiate with the
landlords of the vacated premises acceptable lease termination terms could
result in the Company having to pay such landlords the estimated remaining
amounts due under such leases of $67,500 plus attorneys fees and court costs.
ITEM 3. LEGAL PROCEEDINGS.
On February 6, 1997, the Company received a letter from the counsel to
the Williams family which owns in the aggregate 21,923 shares of the
Company's Common Stock which was acquired for an aggregate purchase price of
$31,950. The Williams family claims Mr. Pidorenko fraudulently induced their
investment and the Company is obligated for personal disputes between Mr.
Pidorenko and this family which primarily concern a disagreement over a
purchase of a personal residence. The Company does not believe it is
obligated to these individuals for personal disputes with Mr. Pidorenko. The
Williams family has rejected the Company's request to purchase their shares
at their original purchase price. The Company believes it has meritorious
defenses to any legal proceedings which may be instituted by such
individuals. Mr. Pidorenko has agreed to indemnify the Company against any
claims asserted by these parties.
To the knowledge of the officers and directors of the Company, other than as
disclosed above and the notes to the financial statements, there are no material
legal proceedings now pending or threatened against the Company.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
On August 12, 1996 the Company declared a 1 for 10 reverse common stock
split.
6
<PAGE>
PART II
ITEM 5. MARKET FOR THE REGISTRANT'S SECURITIES AND RELATED STOCKHOLDER
MATTERS.
7
<PAGE>
The Company's certificate of incorporation, as amended, authorizes
20,000,000 shares of Common Stock, $0.0001 par value and 5,000,000 shares of
preferred stock, $0.0001 par value. Of this total, 2,866,421 shares of Common
Stock are considered outstanding as of March 19, 1997. Additionally, the
Company has reserved 850,000 shares of the Company's Common Stock for issuance
upon exercise of outstanding warrants or options and 275,000 shares
underlying the Underwriters Warrants for the Company's March, 1997 initial
public offering. The Company has 5,000,000 shares of Preferred Stock
outstanding designated as the Series A Convertible Voting Preferred Stock
(the "Voting Preferred Stock"). Mr. Pidorenko is the holder of 5,000,000
shares of Voting Preferred Stock. Each share of Voting Preferred Stock is
entitled to one-half (1/2) vote per share on all matters submitted to a vote
of Common Stockholders.
COMMON STOCK
Holders of shares of Common Stock are entitled to dividends when and as
declared by the Board of Directors from funds legally available therefor and
upon liquidation are entitled to share ratably in any distribution to
stockholders. All holders of Common Stock are entitled to one vote per share on
any matter coming before the stockholders for a vote, including the election of
directors. In keeping with stockholder democracy rights, the Company's
Certificate of Incorporation permits the stockholders to remove any director or
the entire board of directors, with or without cause, upon a vote of a majority
of the outstanding shares.
All issued and outstanding shares of Common Stock are validly issued, fully
paid and non-assessable. Holders of the Common Stock do not have pre-emptive
rights or other rights to subscribe for unissued or treasury shares or
securities convertible into shares.
Under the Florida General Corporation Law, the Company has availed itself of
the provisions permitting the limitation of liability through the
indemnification of officers, directors, employees and agents of Florida
corporations.
PREFERRED STOCK
The Company has outstanding 5,000,000 shares of Voting Preferred Stock,
all of which are held by Mr. Pidorenko. The Voting Preferred Stock has the
right to cast one-half vote per share on each and any matter on which the
Common Stock is entitled to vote. Accordingly, Mr. Pidorenko, is able to
control the affairs and operations of the Company including, but not limited
to, election of directors, sale of assets or other business opportunities.
In addition to preferential voting rights, the Voting Preferred Stock
held by Mr. Pidorenko is subject to conversion into shares of Common Stock if
the Company meets certain earning targets after the closing of the Company's
public offering. The Voting of Preferred Stock has no dividend rights,
redemption provisions or preemptive rights.
8
<PAGE>
WARRANTS
The Warrants issued in the initial public offering are subject to the
terms and conditions of a Warrant Agreement between the Company and Corporate
Stock Transfer, Denver, Colorado, as Warrant Agent. The following description
of the Warrants is not complete and is qualified in all respects by the
Warrant Agreement which was filed as an exhibit to the Registration Statement
for the initial public offering.
Each Warrant entitles the holder thereof to purchase one (1) share of
Common Stock during the period commencing twelve (12) months from March 12,
1997 and expiring at the close of business on the last day of the four (4)
year period following. The exercise price of the Warrants shall be $4.25 per
share. The Company may call the Warrants for a redemption price of $.10 per
Warrant commencing eighteen (18) months after March 12, 1997 (or earlier at
the sole discretion of the Underwriter) if notice of not less than thirty
(30) days is given and the closing sale price of the Common Stock has been at
least 250% of the then exercise price of the Warrants on all twenty (20) of
the trading days ending on the third day prior to the day on which notice is
given.
The exercise price of the Warrants was determined by negotiations between
the Company and the Underwriter. In determining the price, the Company and
the Underwriter of the public offering considered a number of factors,
including the prospects of the Company and the industry in which it competes,
an assessment of the Company's management and the general conditions of the
securities market. The Company may, at the sole discretion of its Board of
Directors, reduce the exercise price (upon effectiveness of a post-effective
amendment to the registration statement under the Securities Act), increase
the number of shares that may be purchased upon exercise of a Warrant and/or
extend the expiration date of the Warrants should it deem that such actions
are in the best interests of the Company.
The Warrants contain adjustment provisions to avoid dilution of the equity
interest represented by the underlying shares upon the occurrence of certain
events, such as share dividends or splits. The Warrants do not have
anti-dilution protection if the Company issues equity securities at a price
below the Warrant exercise price. In the event of liquidation, dissolution or
winding up of the Company, Warrant Holders will not be entitled to receive any
assets of the Company available for distribution to the holders of Common Stock.
Warrants Holders will have no voting, pre-emptive, liquidation or other rights
of a stockholder, and no dividends will be declared on the Warrants.
The Warrants may be exercised upon surrender of the applicable Warrant
certificate on or prior to the expiration of the Warrant exercise period,
accompanied by payment in full of the exercise price for the number of Warrants
being exercised.
The Company has agreed to use its best efforts to maintain the
effectiveness of the Registration Statement for the Warrants under the
Securities Act for the Common Stock underlying the Warrants and to take such
other actions under the laws of various States as may be required to cause
the lawful sale of securities upon the exercise of Warrants if, in the
opinion of the Board of Directors, upon advice of counsel, the sale of
securities upon such exercise would be unlawful. In addition to the 1,375,000
Warrants which were offered in the public offerings, the Company may issue up
to 137,500 Warrants included in the Units issuable upon exercise of the
Underwriter's Warrants.
CERTAIN FEDERAL INCOME TAX MATTERS
The following is a brief summary of certain federal income tax consequences
associated with the purchase and ownership of the Units, the Common Stock and
Warrants included in the Units and the exercise of the Warrants. Prospective
investors are urged to consult with their individual tax advisors concerning the
tax aspects of the Units in their own particular circumstances.
9
<PAGE>
For federal income tax purposes, the issue price of a Unit must be allocated
between the Common Stock and the Warrant included in the Units in proportion to
their respective fair market values at the time of issuance. The amount
allocated to each component element in the Unit will constitute the tax basis of
that element. Upon exercise of a Warrant, the basis of the Warrant plus the
amount paid on the exercise of the Warrant will be the basis of the new share of
Common Stock issued with respect thereto.
No gain or loss will be recognized upon the exercise of a Warrant (nor will
the Company recognize any income upon the exercise of a Warrant). The holding
period of a share of Common Stock acquired upon the exercise of a Warrant will
commence upon the exercise date of the Warrant. Any gain or loss recognized by a
holder upon the sale of a share of Common Stock will generally constitute a
capital gain or capital loss. Any loss recognized upon the lapse of a Warrant
would ordinarily constitute a capital loss.
The federal income tax considerations discussed above are based upon the
current provisions of the Internal Revenue Code, and there can no assurance that
such provisions will not be changed in the future, either prospectively or
retroactively.
SHARES ELIGIBLE FOR FUTURE SALE
As of March 19, 1997, the Company had outstanding 2,886,421 shares of its
Common Stock. Of this amount, 416,067 shares of Common Stock were registered
on behalf of Mr. Pidorenko. Holders of 1,198,096 shares of Common Stock (94%
of current outstanding shares) have agreed not to sell their shares until at
least March 12, 1999, without the Underwriter's consent. The Underwriter has
the right to extend this lock-up period for one (1) additional year if the
Company has not achieved during any 12 consecutive month period a cumulative
pre-tax profit or income, calculated in accordance with GAAP, of at least
$3,000,000. The Underwriter has agreed not to release any stockholder (other
than the shares registered on behalf of Mr. Pidorenko) from their lock-up
provision until at least March 12, 1998. Approximately 87,075 shares of the
Company's common stock are available for resale pursuant to Rule 144. The
possibility of future sales by existing stockholders under Rule 144 or
otherwise may, in the future, have a depressive effect on the market price of
the Common Stock, and such sales, if substantial, might also adversely affect
the Company's ability to raise additional capital.
Generally under Rule 144, a person holding restricted securities for a
period of one year may, if there is adequate public information available
concerning the Company, sell every three months in ordinary brokerage
transactions or transactions with a market maker an amount equal to the greater
of (a) 1% of the Company's then outstanding stock or (b) the average weekly
volume of sales during the four calendar weeks preceding the sale 90 days after
the date of this Prospectus. Rule 144 does not limit the amount of restricted
securities which a person who is not an affiliate of the Company may sell after
three years. Affiliate sales under Rule 144 are subject to such volume
limitations regardless of the length of the holding period. Sales under Rule 144
may, in the future, have a depressive effect on the market price of the
Company's securities should a public market develop.
Future sales of the Common Stock underlying the Warrants, the Underwriter's
Warrants, and options granted for issuance under stock option plans, or to Mr.
Pidorenko pursuant to Rule 144 or otherwise, could depress the market price of
Common Stock. The Company is unable to predict when such options, warrants or
other commitments to purchase the Common Stock of the Company would in fact be
exercised.
MARKET VALUE
Prior to the Company's public offering which closed on March 19, 1997,
there was no market for the Company's Common Stock, Units or Warrants.
Consequently, the offering price of the Units and Warrant Exercise Price were
determined arbitrarily by negotiation between the Company and the
Underwriter. Among the factors considered in such negotiations were
estimates of the business potential of the Company, the present state of its
development of new products, its financial condition, an assessment of its
management and the general condition of the securities markets at the time of
this offering.
On March 19, 1997, 1,375,000 Units of the Company's securities (each
Unit consisting of one share of Common Stock and ten Redeemable Warrants)
were issued to investors at $4.25 per unit. Trading of such Units commenced
thereafter. On March 19, 1997, the Underwriter commenced trading of the
Common Stock and Warrants separately.
The Company's Units, Common Stock, Warrants are listed and traded on
NASDAQ under the symbols, VCLLV, VCLL and VCLLW, respectively.
The following table sets forth for the periods indicated the range of
high bid and low bid closing quotations for the securities indicated as
reported by NASDAQ. These quotations are between dealers, do not include
retail mark-ups, mark-downs or other fees or commissions, and may not
represent actual ??????.
Common Redeemable
Units Stock Warrants
-------------- -------------- -------------
Closing Bid Closing Bid Closing Bid
High Low High Low High Low
1997
- ----
March 19 - April 19(1) $16.00 $8.75 $11.00 $6.00 $6.00 $2.75
As of March 31, 1997, there were approximately __ holders of record of
the Common Stock and __ holders of record of the Warrants.
(1) Prior to March 1997, there was no active trading in the Company's
securities.
DIVIDEND POLICY
The Company has not paid any dividends on its Common Stock and does not
intend to pay cash dividends on its Common Stock in the foreseeable future.
The Company intends to follow a policy of retaining earnings, if any, to
finance the development and expansion of its business.
UNDERWRITERS' SECURITIES
In connection with the public offering, the Company sold to the
Underwriter Options to purchase 137,500 Units of the Company's securities,
identical to the Units publicly sold, at an exercise price of 165% of the
public offering price. Such Underwriters' Units shall be exercisable at a
price per Unit of $6.00 subject to certain adjustments, until March 12, 2001,
when the Underwriters' Options will expire.
The Underwriters' Warrants contained in the Underwriters' Units
underlying the Underwriters' Options contain certain registration rights and
anti-dilution provisions. The holders of the Underwriters' Warrants have no
voting, dividend or other rights as shareholders of the Company with respect
to the shares underlying the Warrants.
TRANSFER AGENT AND WARRANT AGENT Continental Stock Transfer & Trust
Company, New York, New York acts as the Company's Transfer Agent and Warrant
Agent.
10
<PAGE>
ITEM 6. SELECTED FINANCIAL DATA.
The following presents selected financial information of the Company as of
November 30, 1995 and 1996. The financial statements as of November 30, 1995 and
1996, and the report of the Independent Certified Public Accountants thereon are
included elsewhere in this Prospectus. The information set forth below is
qualified by, and should be read in conjunction with, the financial statements
and related notes thereto in their entirety.
<TABLE>
<CAPTION>
YEARS ENDED NOVEMBER 30,
--------------------------
1996 1995
------------- -----------
<S> <C> <C>
INCOME STATEMENT DATA (1)
Total revenue......................................................................... $ 615,845 $ 43,691
Net loss.............................................................................. $ (1,033,553) $ (314,857)
Net loss per share.................................................................... $ (1.34) $ (0.53)
Shares used in per share computation.................................................. 771,154 626,191
</TABLE>
<TABLE>
<CAPTION>
AS OF NOVEMBER 30,
-------------------------- AS
1996 1995 ADJUSTED (3)(4)
------------- ----------- --------------
<S> <C> <C> <C>
BALANCE SHEET DATA
Total assets...................................................... $ 1,537,273 $ 734,733 $ 5,012,273
Working capital................................................... $ (2,444,417) $ (874,313 (2) $ 2,962,886
Long-term debt.................................................... $ -- $ -- $ --
Stockholders' equity.............................................. $ (1,363,939) $ (330,395) $ 4,043,334
Net tangible book value........................................... $ (1,475,950) $ (448,719) $ 3,259,775
Net tangible book value per share................................. $ (1.70) $ (0.67) $ 1.23
</TABLE>
- ------------------------
(1) Excludes operating activity of Darling Paint, which the Company acquired
November 30, 1995. Had the operations of the paint company been included in
the Company's financial statements for the year ended November 30, 1995, a
summary pro forma effect on the Company's operating results would have been
as follows:
<TABLE>
<CAPTION>
YEAR ENDED
NOVEMBER 30,
1995
------------
<S> <C>
Total revenue............................................................................. $ 458,041
Net loss.................................................................................. $ (268,989)
Net loss per share........................................................................ $ (0.43)
Shares used in per share computation...................................................... 626,191
</TABLE>
(2) Includes convertible debt of $740,203 and $1,898,500 at November 30, 1995
and 1996, respectively. $598,500 of these convertible notes plus accrued
interest thereon were exchanged for 373,803 shares of Common Stock by such
note holders.
(3) Adjusted to reflect the sale of the Offering after deduction of the
underwriting discounts and commissions payable by the Company, and estimated
offering expenses.
(4) Excludes the (i) Warrants, Underwriter's Warrants and Over-Allotment Option,
(ii) 350,000 shares received for issuance under the Company's 1996 Stock
Option Plan and (iii) 500,000 shares reserved for the exercise of options
granted to Mr. Pidorenko in connection with his employment agreement
exercisable at $4.00 for 5 years. Also includes the effect of issuing
373,803 shares of common stock to retire $598,500 of certain convertible
note obligation plus accrued interest thereon.
11
<PAGE>
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
DEVELOPMENTAL STAGE ACTIVITIES
The Company had been a developmental stage enterprise during its initial
three years of operation. During this period, management devoted the majority of
its efforts to research and development, financing, purchasing and activities
related to starting up production and marketing. These activities were funded by
investments from stockholders and borrowings from unrelated third parties. The
Company has not generated sufficient revenues during its limited operating
history to fund its ongoing operating expenses, repay its outstanding
indebtedness or to fund its product development activities. In fiscal year 1994,
the Company completed the development of its first product line.
The Company has sustained significant operating losses since its
inception resulting in an accumulated deficit of approximately $(1,548,840)
at November 30, 1996. As of November 30, 1996, the Company has a negative
net tangible net worth of $(1,475,950) and negative working capital of
$(2,444,417). The Company's independent auditors in their report regarding
the Company's financial statement as of November 30, 1996, indicate that
since the Company has a history of recurring losses from operations and
insufficient cash resources to fund a plan of operations, substantial doubt
exists as to the Company's ability to continue as a going concern.
Management's strategy of expanding the ThermaCool-TM- product line,
developing a commercialy viable manufacturing process for shells and
expansion into new markets for its shell technology will result in the
Company incurring substantial additional losses due to the costs associated
with these strategies. The Company is not currently generating sufficient
revenues from its operations to repay existing indebtedness or fund product
development activities. The Company expects to use a portion of the net
proceeds of this offering for repayment of certain of its existing
indebtedness and for general working capital purposes. The Company will
continue to incur significant losses until the Company is able to increase
its sales, expand its product line and increase its distribution capabilities
sufficiently to offset ongoing operating and expansion costs. There can be
no assurance that the Company will ever generate sufficient revenues to allow
the Company to achieve profitable operations.
RESULTS OF OPERATIONS
FISCAL YEAR 1996 COMPARED TO FISCAL YEAR 1995
Total revenue for the year ended November 30, 1996, was $615,845 compared
to $43,691 for the same period of 1995, which represents an increase of
$583,154. The increase was a result of expanded sales of paint products and
coatings produced by the Company's paint manufacturing facility acquired in
the 1995 fiscal year. The increased sales were a direct result of increased
marketing efforts and production capabilities. The net loss and the net loss
per share were $1,033,553 and $1.34 per share respectively, for the year
ended November 30, 1996, as compared to a net loss and net loss per share of
$314,857 and $.50, respectively, for the same period of 1995. As discussed
below under "Liquidity and Capital Resources", the Company plans to institute
a marketing campaign to cover the sunbelt region of the United States.
For the year ended November 30, 1996, total selling, general and
administrative expenses were $1,280,339, as compared to $376,919 for the same
period of the previous year, an increase of $903,420. The increases were due to
expenses incurred with the initial production of the Company's proprietary
products in its newly acquired manufacturing facility, expenses incurred in
relation to the refinement of the formulations of the paint and paint coatings
being manufactured, as well as costs associated with increased marketing
efforts, staffing and other expenses associated with the Company's expanded
operations.
In June 1996, the Company opened a new retail location in Sarasota, FL
based upon the prospects of completing a public offering in the near term.
Due to the failure of the prior offering, the Company experienced negative
cash flow. In a effort to streamline operations and cut costs, management
closed the Sarasota location in January 1997. The effect of this closure is
an anticipated reduction of $10,000 per month in the Company's operating
costs. In addition to the above retail store closure, the Company also closed
its executive offices in Tampa, FL and relocated all operations to the
manufacturing facility in New Port Richey, FL. This closure will result in a
monthly reduction of $7,000 per month in operating costs. Additionally, the
Company executives have reduced their pay by a cumulative amount of $6,500
per month. The total cost savings of these actions reduced company operating
costs by $23,500 per month or $282,000 on an annual basis.
FISCAL YEAR 1995 COMPARED TO FISCAL YEAR 1994
During the period from inception through November 30, 1994, the Company
realized revenues of $17,800. The Company was a developmental stage company and
was continuing the development of its first products.
Net revenues of approximately $43,700 for the fiscal year ended November 30,
1995, represent an increase of 145% over the prior year, resulting primarily
from increased sales of the Company's roof products. While the revenue volume of
the 1994 and 1995 fiscal years is indicative of the Company's developmental
state, the Company is expected to become fully operational in fiscal year 1996.
12
<PAGE>
Cost of sales for the 12 months ended November 30, 1994 and 1995 were
approximately $25,300 and $15,400, respectively. Management expects the cost of
sales as a percentage of sales to decrease due to better utilization of
production capabilities and improved purchasing methods. Cost of sales for
fiscal year 1995 and 1994 were higher than normal in relation to sales due to
the need to give samples to prospective customers, as well as the necessity to
pay third parties to manufacture and sell the Company's product. If the Company
obtains increased market recognition and curtails the voluminous testing
required during the developmental stage, the volume of samples to be provided
may decrease, therefore reducing the cost of sales.
Operating expenses totaled approximately $616,600 for the period from
inception through November 30, 1995. Total operating expenses were $377,000 in
fiscal year 1995 and $239,700 in fiscal year 1994. Expenses in 1994 were
primarily incurred in connection with product research and development
activities. In 1995, the Company incurred significant expenses related to sales
activities of introducing the initial products to the marketplace, as well as
legal fees and financing costs incurred in seeking and obtaining funding and in
acquiring Darling Paint, a paint manufacturing company.
The Company has accumulated net operating losses of $640,944 for the period
from inception through November 30, 1995.
DARLING PAINT
Development of roof and wall coatings has been an ongoing process that has
progressed from the Company's product being manufactured by a third party to its
current capability of manufacturing its own paint and coating products. The
acquisition of the operating assets of Darling Paint, effective November 30,
1995 for $251,016, provides the Company with the production equipment and
initial distribution channels for its products.
The Company has improved its purchasing procedures, by buying to support
larger production volumes and expanding its supplier base. As a result, the cost
of manufactured products has dropped significantly. The reduced costs are
expected to continue to be realized or improved during fiscal year 1997.
However, increased costs associated with marketing and expansion are expected to
offset any cost savings associated with improved cost of goods due to the
Darling Paint acquisition.
LIQUIDITY AND CAPITAL RESOURCES
The Company has funded its initial capital operations and product
development activities with funds provided by the sale of its securities and
from borrowings.
During fiscal years 1994 and 1995, the Company raised approximately $184,400
through issuance of its Common Stock. During fiscal years 1995 and 1996, the
Company raised approximately $1,898,500 through the private placement of its
convertible notes, notes and Common Stock. $598,500 of certain convertible notes
plus accrued interest thereon were exchanged into 373,803 shares of Common Stock
as a condition to this Offering required by the Underwriter. The Company
anticipates satisfying or has satisfied all indebtedness relating to these
obligations either through the payment of such notes with the proceeds of the
public offering or the conversion of certain of these notes into shares of the
Company's Common Stock and the undertaking of the Company's chief executive
officer to personally assume certain of these obligations.
The Company's operating losses have resulted in working capital and
stockholders' equity deficits of approximately $2,444,417 and $1,363,939 at
November 30, 1996, respectively. The Company is not presently generating
sufficient revenues from operations to fund capital requirements. The ability of
the Company to alleviate its working capital deficit and obtain capital adequate
to fund future costs associated with operations and expansion plans is dependent
upon successful completion of the public offering and realization of projected
increases in sales of new product lines.
13
<PAGE>
In the opinion of management, the net proceeds from the public offering
are providing sufficient working capital to enable the Company to finance
planned expansion for the next twelve months without the need for additional
capital. However, the Company will require substantial revenues from the sale
of ThermaCool-TM- products in addition to the proceeds of the public offering
in order to fund anticipated operations for the twenty-four months after the
closing of the offering. There is no assurance that such revenues will be
generated or that other funding will be available to the Company.
SEASONALITY AND FLUCTUATIONS IN QUARTERLY OPERATING RESULTS
The Company believes it will experience stronger demand for its products in
the spring, summer and fall of each year. By directing its marketing efforts to
the warmer states, the Company feels that fluctuations resulting from
seasonality will be minimized.
INFLATION
Inflation has not proven to be a factor in the Company's business since its
inception and is not expected to have a material impact on the Company's
business in the foreseeable future.
14
<PAGE>
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.
The information required by Item 8 appears at page F-1, which appears
after this page.
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE.
Not applicable.
15
<PAGE>
THERMACELL TECHNOLOGIES, INC.
FINANCIAL STATEMENTS
NOVEMBER 30, 1995 AND 1996
<PAGE>
INDEX TO FINANCIAL STATEMENTS
<TABLE>
<CAPTION>
PAGE
---------
<S> <C>
Report of Independent Certified Public Accountants................................................... 2
Balance Sheets....................................................................................... 3
Statements of Loss................................................................................... 4
Statements of Changes in Stockholders' Equity........................................................ 5
Statements of Cash Flows............................................................................. 6
Notes to Financial Statements........................................................................ 7-16
</TABLE>
<PAGE>
[LOGO]
REPORT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS
To Board of Directors
ThermaCell Technologies, Inc.
Tampa, Florida
We have audited the accompanying balance sheets of ThermaCell Technologies,
Inc. as of November 30, 1995 and 1996 and the related statements of loss,
changes in stockholders' equity, and cash flows for the years then ended and the
period from August 12, 1993 (inception) to November 30, 1995. These financial
statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these financial statements based on
our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly,
in all material respects, the financial position of ThermaCell Technologies,
Inc. as of November 30, 1995 and 1996 and the results of its operations and its
cash flows for the years ended and the period from August 12, 1993 (inception)
to November 30, 1995 in conformity with generally accepted accounting
principles.
As described in Note 2 to the financial statements, the accompanying
financial statements have been prepared assuming the Company will continue as a
going concern. As shown in the financial statements, the Company's accumulated
deficit at November 30, 1996 was $1,548,840. At November 30, 1996, the Company's
current liabilities exceeded current assets by $2,444,417. These conditions
raise substantial doubt about the Company's ability to continue as a going
concern. Management's plans regarding these matters are further described in
Note 2. The financial statements do not include any adjustments that might
result from the outcome of this uncertainty.
/s/ Cherry Bekaert & Holland, L.L.P.
Clearwater, Florida
January 15, 1997
except for Note 17 as to which
the date is February 7, 1997
<PAGE>
THERMACELL TECHNOLOGIES, INC.
BALANCE SHEETS
NOVEMBER 30, 1995 AND 1996
ASSETS
<TABLE>
<CAPTION>
1995 1996
--------- ----------
<S> <C> <C>
CURRENT ASSETS
Cash.................................................................................... $ 90,773 $ 3,512
Notes receivable........................................................................ 213,750
Accounts receivable
Trade, net of allowance for uncollectible accounts of $21,000 for 1996................ 2,677 64,006
Employees............................................................................. 224 --
Officers.............................................................................. 18,582 4,637
Other................................................................................. -- 6,000
--------- ----------
21,483 74,643
--------- ----------
Inventories............................................................................. 71,016 150,872
Prepaid assets.......................................................................... -- 7,695
Deposits................................................................................ 7,543 6,323
--------- ----------
TOTAL CURRENT ASSETS................................................................ 190,815 456,795
--------- ----------
PROPERTY AND EQUIPMENT.................................................................... 114,373 322,979
Less accumulated depreciation........................................................... 11,011 41,060
--------- ----------
103,362 281,919
--------- ----------
OTHER ASSETS
Note receivable......................................................................... 100,000 --
Restricted cash......................................................................... -- 15,000
Organizational costs, net............................................................... 2,445 2,604
Patents................................................................................. 10,058 14,271
Trademark............................................................................... -- 3,036
Agreement not to compete, net........................................................... 25,000 16,667
Deferred offering costs................................................................. 16,590 297,648
Deferred Loan Costs, net................................................................ 79,985 36,550
Deferred income tax benefit, net........................................................ 125,657 337,350
Goodwill, net........................................................................... 80,821 75,433
--------- ----------
440,556 798,559
--------- ----------
$ 734,733 $1,537,273
--------- ----------
--------- ----------
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Notes payable
Bridge financing........................................................................ $ 740,203 $1,898,500
Stockholders............................................................................ 203,304 135,000
Other................................................................................... -- 24,323
--------- ----------
943,507 2,057,823
Accounts payable and accrued expenses
Trade accounts.......................................................................... 16,181 444,537
Accrued payroll and payroll taxes....................................................... 55,024 175,696
Accrued interest........................................................................ 29,396 223,156
Commissions payable..................................................................... 21,020 --
--------- ----------
TOTAL CURRENT LIABILITIES........................................................... 1,065,128 2,901,212
--------- ----------
STOCKHOLDERS' EQUITY
Preferred stock, par value $.0001
5,000,000 shares authorized, issued and outstanding, 1995 and 1996.................... 500 500
Common stock, par value $.0001.
Authorized 20,000,000 shares, outstanding 667,472 and 869,899 shares, 1995 and 1996,
respectively......................................................................... 66 87
Additional paid-in capital.............................................................. 184,326 184,314
Accumulated deficit:
During developmental stage............................................................ (515,287) (515,287)
Subsequent to developmental stage..................................................... -- (1,033,553)
--------- ----------
Total accumulated deficit........................................................... (515,287) (1,548,840)
--------- ----------
TOTAL STOCKHOLDERS' EQUITY........................................................ (330,395) (1,363,939)
--------- ----------
$ 734,733 $1,537,273
--------- ----------
--------- ----------
</TABLE>
See notes to financial statements.
3
<PAGE>
THERMACELL TECHNOLOGIES, INC.
STATEMENTS OF LOSS
<TABLE>
<CAPTION>
PERIOD FROM FOR THE YEARS ENDED
AUGUST 12, 1993 NOVEMBER 30,
(INCEPTION) TO --------------------------
NOVEMBER 30, 1995 1995 1996
----------------- ----------- -------------
<S> <C> <C> <C>
REVENUE
Sales........................................................... $ 61,473 $ 43,691 $ 615,845
LESS COST OF SALES................................................ 40,722 15,431 394,867
----------------- ----------- -------------
GROSS PROFIT.................................................. 20,751 28,260 220,978
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES...................... 616,594 376,919 1,280,339
----------------- ----------- -------------
LOSS FROM OPERATIONS.......................................... (595,843) (348,659) (1,059,361)
----------------- ----------- -------------
OTHER INCOME (EXPENSE)
Commissions..................................................... 20,448 2,272 --
Interest income................................................. -- -- 24,763
Interest expense................................................ (65,549) (47,645) (207,147)
Loss on sale of fixed assets.................................... -- -- (3,500)
----------------- ----------- -------------
TOTAL OTHER INCOME (EXPENSE).................................. (45,101) (45,373) (185,884)
----------------- ----------- -------------
LOSS BEFORE INCOME TAXES...................................... (640,944) (394,032) (1,245,245)
INCOME TAXES
Deferred income tax benefit..................................... 125,657 79,175 211,692
----------------- ----------- -------------
NET LOSS...................................................... $ (515,287) $ (314,857) $ (1,033,553)
----------------- ----------- -------------
----------------- ----------- -------------
Loss per common share............................................. $ (0.50) $ (1.34)
----------- -------------
----------- -------------
Weighted average number of common share outstanding............... 626,191 771,154
----------- -------------
----------- -------------
</TABLE>
See notes to financial statements.
4
<PAGE>
THERMACELL TECHNOLOGIES, INC.
STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
<TABLE>
<CAPTION>
COMMON STOCK PREFERRED STOCK
------------------------ ------------------------ ADDITIONAL
NUMBER OF NUMBER OF PAID-IN ACCUMULATED
SHARES AMOUNT SHARES AMOUNT CAPITAL DEFICIT TOTAL
----------- ----------- ----------- ----------- ----------- ------------ ----------
<S> <C> <C> <C> <C> <C> <C> <C>
Issuance of common stock for cash..... 5,669,551 $ 567 -- $ -- $ 177,383 $ -- $ 177,950
Issuance of preferred stock for
cash................................. -- -- 4,975,000 497 45 -- 542
Issuance of common stock under
employment contracts................. 60,000 6 -- -- (6) -- --
Issuance of common stock to directors
for services......................... 31,400 3 -- -- (3) -- --
Effect of reverse stock split:
Common -- one for ten shares........ (5,184,855) (519) -- -- 519 -- --
Issuance of stock as perquisite for
providing services................... 30,000 3 -- -- (3) -- --
Net loss for the year ended November
30, 1994............................. -- -- -- -- -- (200,430) (200,430)
----------- ----- ----------- ----- ----------- ------------ ----------
Balance November 30, 1994......... 606,096 60 4,975,000 497 177,935 (200,430) (21,938)
Issuance of common stock for cash..... 11,400 1 -- -- 6,399 -- 6,400
Issuance of common stock under
employment contracts................. 300,000 30 -- -- (30) -- --
Issuance of stock as a perquisite for
providing bridge loan financing...... 52,364 5 -- -- (5) -- --
Issuance of stock to a promoter as a
perquisite........................... 250,000 25 -- -- (25) -- --
Effect of reverse stock split:
Common -- one for ten shares........ (552,388) (55) -- -- 55 -- --
Net loss for the year ended November
30, 1995............................. -- -- -- -- -- (314,857) (314,857)
----------- ----- ----------- ----- ----------- ------------ ----------
Balance November 30, 1995......... 667,472 $ 66 4,975,000 $ 497 $ 184,329 $ (515,287) $ (330,395)
Issuance of common stock as incentive
to employees......................... 19,000 2 -- -- (2) -- --
Issuance of stock as a perquisite for
providing financing/capital.......... 153,227 16 -- -- (7) -- 9
Issuance of stock to a promoter as a
perquisite........................... 20,000 2 -- -- (2) -- --
Issuance of stock as a credit for
services............................. 10,200 1 -- -- (1) -- --
Net loss for the year ended November
30, 1996............................. -- -- -- -- -- (1,033,553) (1,033,553)
----------- ----- ----------- ----- ----------- ------------ ----------
Balance November 30, 1996......... 869,899 $ 87 4,975,000 $ 497 $ 184,317 $(1,548,840) $(1,363,939)
----------- ----- ----------- ----- ----------- ------------ ----------
----------- ----- ----------- ----- ----------- ------------ ----------
</TABLE>
See notes to financial statements.
5
<PAGE>
THERMACELL TECHNOLOGIES, INC.
STATEMENTS OF CASH FLOWS
<TABLE>
<CAPTION>
PERIOD FROM FOR THE YEARS ENDED
AUGUST 12, 1993 NOVEMBER 30,
(INCEPTION) TO ---------------------------
NOVEMBER 30, 1995 1995 1996
----------------- ------------ -------------
<S> <C> <C> <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
Reconciliation of net loss to net cash used in operating
activities
Net loss..................................................... $ (515,287) $ (314,857) $ (1,033,553)
Adjustments to reconcile net loss to net cash used in
operating activities
Depreciation............................................... 11,011 6,606 30,049
Amortization............................................... 810 486 171,930
Loss on sale of capital asset.............................. -- -- 3,500
Deferred income tax benefit................................ (125,657) (79,175) (211,692)
(Increase) decrease in accounts receivable................. (21,483) 8,926 (53,160)
Increase in inventories.................................... (71,016) (71,016) (79,856)
(Increase) decrease in prepaid assets...................... -- -- (7,695)
(Increase) decrease in deposits............................ (7,543) (7,543) 1,220
Increase in other assets................................... (119,134) (110,736) (7,249)
Increase (decrease) in accounts payable.................... 16,181 (8,372) 428,356
Increase in accrued expenses............................... 105,440 105,440 293,412
----------------- ------------ -------------
NET CASH USED IN OPERATING ACTIVITIES.................... (726,678) (470,241) (464,738)
----------------- ------------ -------------
CASH FLOWS FROM INVESTING ACTIVITIES
Capital expenditures........................................... (114,373) (92,349) (213,606)
Proceeds from sale of capital asset............................ -- -- 1,500
Issuance of note receivable.................................... (100,000) (100,000) (115,000)
Collections on notes receivable................................ -- -- 1,250
----------------- ------------ -------------
NET CASH USED IN INVESTING ACTIVITIES.................... (214,373) (192,349) (325,856)
----------------- ------------ -------------
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of common stock......................... 184,892 6,400 68
Proceeds from issuance of notes payable........................ 1,137,707 1,037,707 1,192,822
Principal payments on notes payable............................ (194,200) (194,200) (10,202)
Principal payments on stockholder loans........................ -- -- (68,304)
Costs associated with obtaining financing...................... (96,575) (96,575) (396,051)
----------------- ------------ -------------
NET CASH PROVIDED BY FINANCING ACTIVITIES................ 1,031,824 753,332 718,333
----------------- ------------ -------------
NET INCREASE (DECREASE) IN CASH.......................... 90,773 90,742 (72,261)
CASH BEGINNING................................................... -- 31 90,773
----------------- ------------ -------------
CASH ENDING...................................................... $ 90,773 90,773 $ 18,512
----------------- ------------ -------------
----------------- ------------ -------------
</TABLE>
See notes to financial statements.
6
<PAGE>
THERMACELL TECHNOLOGIES, INC.
NOTES TO FINANCIAL STATEMENTS
NOTE 1--SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
BUSINESS ACTIVITY
The Company was formed August 12, 1993. For the year ended November 30,
1995, the Company was in the developmental stage. During the first three
quarters of fiscal year end 1996, significant manufacturing and sales efforts
began ushering the company out of the development stage by the beginning of the
fourth quarter of that year. Operations prior to that time were devoted
primarily to developing products, raising capital, obtaining financing,
acquiring manufacturing and sales facilities, marketing, and administrative
functions.
INVENTORIES
Inventories are valued using the first-in, first-out (FIFO) method. All
inventories are stated at the lower of cost or market.
PROPERTY AND EQUIPMENT
Property and equipment are recorded at cost less accumulated depreciation.
Depreciation is computed using the straight-line method over the estimated
useful lives of assets.
INTANGIBLE ASSETS
Intangible assets subject to amortization include organization costs,
agreement not to compete, loan costs, trademark, goodwill and patents.
Organizational costs and agreement not to compete are being amortized on a
straight-line basis over five years and three years, respectively. Loan costs
are being amortized using the interest method over the lives of the related
loans. Trademark and goodwill are being amortized on a straight-line basis over
ten and fifteen years, respectively. Amounts attributable to patents will be
amortized over the useful life of the patent (but not more than 20 years)
beginning the month the patent becomes effective.
USE OF ESTIMATES IN THE PREPARATION OF FINANCIAL STATEMENTS
The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosures of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
7
<PAGE>
THERMACELL TECHNOLOGIES, INC.
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
NOTE 1--SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
FAIR VALUE OF FINANCIAL INSTRUMENTS
The estimated fair value of the Company's cash, trade accounts receivable
and payable approximated their carrying value at year end. It is not practicable
to estimate the fair value of other financial instruments held or owned by the
Company including, but not limited to, other receivables and payables due to the
lack of readily available information regarding the marketability of such
instruments and the effect of credit risk on the measurement of fair value for
such instruments.
LOSS PER COMMON SHARE
Primary loss per common share equals net loss divided by the weighted
average number of common shares outstanding. The convertible securities are not
included in the fully diluted earnings per share calculation for November 30,
1995 because they are anti-dilutive. There were no convertible securities at
November 30, 1996 as discussed in Note 7. Consequently, there is no separate
presentation of fully dilutive loss per share.
ADVERTISING
The Company expenses advertising costs as they are incurred.
INCOME TAXES
Income taxes are accounted for by an asset and liability approach for
financial accounting and reporting purposes. Deferred income taxes are provided
based on the estimated future tax effects of differences between financial
statement carrying amounts and the tax bases of existing assets and liabilities,
and are adjusted for changes in tax laws and tax rates when those changes are
enacted. The provision for income taxes represents the total of income taxes
paid or payable for the current year, plus the change in deferred taxes during
the year.
NOTE 2--GOING CONCERN
The accompanying financial statements have been prepared in conformity with
generally accepted accounting principles which contemplate continuation of the
Company as a going concern. However, the Company has sustained substantial
operating losses since its inception. At November 30, 1996, the Company's
accumulated deficit was $1,548,840, and current liabilities exceeded current
assets by $2,444,417.
8
<PAGE>
THERMACELL TECHNOLOGIES, INC.
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
NOTE 2--GOING CONCERN (CONTINUED)
The history of recurring losses from operations and insufficient cash
resources to fund operations raise substantial doubt as to the Company's ability
to continue as a going concern. Management, however, believes the following
actions which are being taken to revise the Company's operating and financial
requirements provide the opportunity for the Company to continue as a going
concern, although no assurance to that effect can be given.
Management is actively seeking an underwriter for a second attempt at an
initial public offering. Management believes the proceeds expected to be
received from the offering will be sufficient to satisfy its anticipated cash
needs for approximately twelve months following the completion of the offering.
Also, management plans to negotiate extensions on all the notes payable.
Management believes that these actions, as well as the implementation of
organizational and operational changes, will enable the Company to continue as a
going concern, although no assurance can be given as to the ultimate success of
any of these actions. The Company is also currently investigating options to
merge with an existing public company or to sell to interested buyers, should
the offer fail to close.
NOTE 3--INVENTORIES
Inventories consist of the following at November 30, 1995 and 1996:
<TABLE>
<CAPTION>
1995 1996
--------- ----------
<S> <C> <C>
Raw Materials.................................................................... $ 36,633 76,374
Finished goods (manufactured and purchased)...................................... 34,383 74,498
--------- ----------
$ 71,016 $ 105,872
--------- ----------
--------- ----------
</TABLE>
NOTE 4--RESTRICTED CASH
Cash restricted for payment to former note holder and held in agency by the
Company was $15,000 at November 30, 1996.
NOTE 5--NOTES RECEIVABLE
A note receivable of $200,000 at November 30, 1996 is from an unrelated
third party. Quarterly payments of interest at twelve percent commenced March 6,
1996, with full payment due by December 17, 1996. The note is collateralized by
equity securities. Subsequent to fiscal year end November 30, 1996, the note
went into default. However, no allowance for uncollectible amount has been
recorded because of the settlement agreement as discussed in Note 16.
An unsecured, non-interest bearing note receivable of $13,750 at November
30, 1996 is from a customer of the Company. Monthly principal payments commenced
in November 1996, and full payment is due September 17, 1997.
9
<PAGE>
THERMACELL TECHNOLOGIES, INC.
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
NOTE 6--PROPERTY AND EQUIPMENT
Property and equipment consisted of the following at November 30, 1995 and
1996:
<TABLE>
<CAPTION>
1995 1996
---------- ----------
<S> <C> <C>
Furniture and fixtures.......................................................... $ 34,732 $ 38,233
Equipment....................................................................... 78,991 255,473
Vehicles........................................................................ -- 26,023
Leasehold improvements.......................................................... 650 3,250
---------- ----------
Total cost...................................................................... 114,373 322,979
Accumulated depreciation........................................................ 11,011 41,060
---------- ----------
Property and equipment, net..................................................... $ 103,362 $ 281,919
---------- ----------
---------- ----------
</TABLE>
NOTE 7--BRIDGE FINANCING
In September 1995, the Company commenced a private placement offering of
securities in the form of convertible unsecured notes in order to obtain
funds to be used for working capital, to pay operating expenses, to acquire a
complementary paint company or equipment necessary to manufacture the
Company's insulative coatings, and to pay the organizational and underwriting
costs to be incurred in an initial public offering of the Company's stock. A
second offering of unsecured notes and common stock was commenced January
1996 to obtain additional funds for the purposes stated above. The selling
agents received up to ten percent (10%) of the amounts raised.
Included in notes payable at November 30, 1995 and 1996 are $740,203 and
$1,898,500, respectively, representing the aggregate amount raised by the
Company in various debt related offerings as of those dates. Included in those
amounts are $740,203 and $1,898,500 at November 30, 1995 and 1996, respectively,
raised by the selling agents through the issuance of the securities under
private placement offerings described above. The notes bear interest at the rate
of twelve percent (12%), with principal and interest due on the earlier of the
date of the closing of the public offering or one year from the date of the
notes, which were executed during the period October 15, 1995 through July 26,
1996. The notes contain a provision for penalty upon default. The notes were
convertible, at the option of the holder, to an amount of common stock based
between 50% to 60% of the price of the shares of the Company's common stock to
be offered in the public offering. The option to convert was conditioned upon
the closing of the initial public offering of the Company's stock. Because the
closing did not occur, the notes are payable at the original one year maturity
date. At November 30, 1996, $505,000 of these notes were in default. As of the
date of the auditors' report, approximately $1.3 million of the notes were in
default.
10
<PAGE>
THERMACELL TECHNOLOGIES, INC.
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
NOTE 8--RELATED PARTY TRANSACTIONS
The Company leased vehicles from an individual who is its president and
stockholder. Total lease expense for 1995 was $9,600.
The Company has notes payable to stockholders at November 30, 1995 and 1996
of $203,304 and $135,000, respectively. The notes were issued on varying dates
and are due one year from the date of issuance, plus interest at 12% to 15%. The
notes were in default at November 30, 1996.
The Company had sales of $83,339 during fiscal year 1996 with individuals
and companies which are stockholders. The Company had sales of $12,164 during
fiscal year 1996 with individuals and companies which are both stockholders and
directors.
The Company had bridge financing notes payable held by stockholders of
$117,500 at November 30, 1995 and 1996.
The Company received $121,060 in legal services from a law firm which is a
stockholder and had an account payable of $11,589 and $110,470 at November 30,
1995 and 1996, respectively.
During fiscal year 1996, the Company purchased a vehicle from an individual
who is its president and stockholder. The vehicle was subsequently sold by the
Company to a third party for a loss of $3,500.
During fiscal year 1996, the Company advanced $257,134 and received payment
of advances of $226,031 to an individual who is its president and stockholder.
The balance due to the Company at November 30, 1996 was $4,277.
NOTE 9--STOCK TRANSACTIONS
In April 1996, the Company effected a one-for-ten reverse stock split and
increased the number of common shares authorized from 10,000,000 shares to
20,000,000 shares. All references in the 1995 financial statements to numbers of
common shares and loss per share amounts have been restated to give retroactive
effect to the reverse stock split.
The Company has two employment contracts which provide for granting shares
of stock for years of service to an officer and a key employee. The Company's
president was awarded options exercisable for five years which entitle him to
acquire up to 500,000 shares of the Company's common stock at a price to be
determined upon closing of the Company's initial public offering. In addition,
the Company from time to time grants stock incentive awards to officers and
other key employees. There were no awards outstanding under the Company's
various agreements at November 30, 1995 and 1996.
11
<PAGE>
THERMACELL TECHNOLOGIES, INC.
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
NOTE 10--OPERATING LEASES
The Company leases a building, office space, office equipment, and a vehicle
under operating leases. The leases expire at various dates through 1999. Rental
expense under these leases was $6,069 and $100,944 for 1995 and 1996,
respectively.
The following is a schedule by years of minimum rentals under the above
lease agreements as of November 30, 1996.
Year ending November 30
1997................................ $ 114,207
1998................................ 108,062
1999................................ 19,727
---------
$ 241,996
---------
---------
NOTE 11--RESEARCH AND DEVELOPMENT COSTS
Research and development cost included in the statements of loss totaled
$557 and $9,500 for the year ended November 30, 1995 and 1996, respectively.
NOTE 12--SUPPLEMENTAL CASH FLOW INFORMATION
Interest paid totaled $17,887 and $13,198 for the years ended November 30,
1995 and 1996, respectively.
NOTE 13--CONCENTRATION OF CREDIT RISK
The Company operates from two locations in West Central Florida and
manufactures and sells paint and related products. The Company extends credit to
its customers substantially without collateral. The business operations are
influenced by the general economic conditions of the surrounding area.
NOTE 14--ACQUISITION OF PAINT MANUFACTURING COMPANY
The Company entered into an agreement to purchase the operating assets of
C.F. Darling Paint & Chemicals, Inc. (Paint Company), a paint manufacturing
company in West Central Florida, effective November 30, 1995. The total purchase
price of $251,016 was paid in cash at time of closing. The acquisition was
accounted for as a purchase. Accordingly, the purchase price was allocated to
the assets acquired based upon their estimated fair market values. The excess of
the purchase price over the estimated fair market value of assets acquired
amounted to $105,821, of which $25,000 has been accounted for as the estimated
value of the agreement not to compete, and $80,821 is accounted for as goodwill.
12
<PAGE>
THERMACELL TECHNOLOGIES, INC.
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
NOTE 14--ACQUISITION OF PAINT MANUFACTURING COMPANY (CONTINUED)
The operating results of Paint Company have not been included in the
Company's statement of loss for 1995 since the acquisition was completed
effective November 30, 1995. Had the operations of Paint Company been included
in the Company's financial statements for the year ended November 30, 1995, the
pro forma effect on the Company's operating results would have been as follows:
<TABLE>
<CAPTION>
1995 (UNAUDITED)
-----------------------------------------
THERMACELL
TECHNOLOGIES, PAINT
INC. COMPANY TOTAL
---------------- ---------- -----------
<S> <C> <C> <C>
Net Sales............................................................. $ 43,691 $ 414,350 $ 458,041
Cost of sales......................................................... 15,431 209,056 224,487
---------------- ---------- -----------
Gross profit.......................................................... 28,260 205,294 233,554
Selling, general & administrative..................................... 376,919 187,526 564,445
---------------- ---------- -----------
Operating income (loss)............................................... (348,659) 17,768 (330,891)
Interest expense...................................................... (47,645) (1,258) (48,903)
Commissions income.................................................... 2,272 -- 2,272
Other income.......................................................... -- 344 344
Gain on sale of assets................................................ -- 40,000 40,000
---------------- ---------- -----------
Income (loss) before income taxes..................................... (394,032) 56,854 (337,178)
Income taxes - current expense........................................ -- 10,986 10,986
Income taxes - deferred benefit....................................... 79,175 -- 79,175
---------------- ---------- -----------
Net income (loss)..................................................... $ (314,857) $ 45,868 $ (268,989)
---------------- ---------- -----------
---------------- ---------- -----------
Loss per share........................................................ $ (.43)
-----------
-----------
Weighted average number of common shares outstanding.................. 626,191
-----------
-----------
</TABLE>
13
<PAGE>
THERMACELL TECHNOLOGIES, INC.
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
NOTE 14--ACQUISITION OF PAINT MANUFACTURING COMPANY (CONTINUED)
These pro forma results have been prepared for comparative purposes only.
They do not purport to be indicative of the results of operations which actually
would have resulted had the combination been in effect on December 1, 1994 or of
future results of operations of the consolidated entities.
NOTE 15--INCOME TAXES
In accordance with Statement of Financial Accounting Standards No. 109 (SFAS
109) ("Accounting for Income Taxes"), the Company recorded deferred tax assets
to reflect the future tax benefits of financial operating loss carryforwards in
1995 and 1996.
The Company has a net operating loss carryforward of $1,886,189 at November
30, 1996 which expires in 2009 through 2011. Management's determination of an
adequate valuation allowance is based upon its current estimates of future
taxable income. If the Company is unable to generate sufficient taxable income
in the future through operating results, increases in the valuation allowance
will be required through a charge to expense. However, if the Company achieves
sufficient profitability to utilize a greater portion of the deferred tax asset,
the valuation allowance will be reduced through a credit to income.
A valuation allowance is required by SFAS 109 if, based on the weight of
available evidence, it is more likely than not that some portion or all of
the deferred tax assets will not be realized. The need for the valuation
allowance is evaluated periodically by management. Based on available
evidence, management concluded that a valuation allowance of 50 percent is
sufficient at November 30, 1995 and 1996.
Significant components of the Company's net deferred tax assets are as
follows:
<TABLE>
<CAPTION>
1995 1996
----------- -----------
<S> <C> <C>
Deferred taxes................................................................ $ 251,312 $ 674,700
Less: Valuation allowance................................................... (125,655) (337,350)
----------- -----------
Net deferred tax assets................................................... $ 125,657 $ 337,350
----------- -----------
----------- -----------
</TABLE>
Based on management's assessment, it is more likely than not that the net
deferred tax assets will be realized through future taxable earnings.
14
<PAGE>
THERMACELL TECHNOLOGIES, INC.
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
NOTE 16--SUBSEQUENT EVENTS
On January 13, 1997, a nonbinding letter of intent was received from
Ecological Technologies, Inc. proposing to negotiate an exclusive distribution
agreement for the Company's products in Japan. Consummation of the agreement is
subject to a number of conditions including test results in Japan confirming
product performance and agreement by the Company to secure patents in Japan for
the technology. Purchases, based on aforementioned conditions, were proposed in
the following volume:
1997............................................ $ 800,000
1998............................................ $1,000,000
1999............................................ $1,100,000
2000............................................ $1,210,000
2001............................................ $1,331,000
2002 through 2006, 10% increase of prior year.
Either party may terminate the discussions. Due to the contingencies
involved, the Company is unable to predict whether or when a transaction with
Ecological Technologies, Inc. will be consummated.
On December 17, 1996, the collateralized note receivable of $200,000 became
due and was not paid. The Company entered into a settlement agreement with the
maker of the note receivable providing for temporary financing to the Company
and offsets of amounts owed. The agreement resulted in the extinguishment of the
note receivable and a net increase in the Company's liabilities of approximately
$258,000.
On December 6, 1996, the Company borrowed $200,000 from an unrelated third
party. The note bears interest at the rate of one percent (1%) per month, with
principal and interest due on December 17, 1996. The Company is required to pay
all cost of collection for the note payable. The holder of the note, subsequent
to November 30, 1996, made a demand upon the Company for repayment. The Company
is in the process of settling this claim which includes an undertaking by the
Company's chief executive officer to assume all obligations under this note.
On January 13, 1997, the initial public offering failed to close, as
scheduled. If this event had occurred on or prior to November 30, 1996, it would
have increased the loss by $247,048, the amount capitalized as cost related to
the initial public offering, net of related tax benefit.
15
<PAGE>
THERMACELL TECHNOLOGIES, INC.
NOTES TO FINANCIAL STATEMENTS (CONTINUED)
NOTE 16--SUBSEQUENT EVENTS (CONTINUED)
The following proforma presentation shows the effect on the Company's
financial statements:
<TABLE>
<CAPTION>
NOVEMBER 30, 1996
----------------------------
AS REPORTED PRO FORMA
------------- -------------
<S> <C> <C>
Total other assets........................................................ $ 798,559 $ 551,511
------------- -------------
Total assets.............................................................. $ 1,537,273 $ 1,290,225
------------- -------------
------------- -------------
Total stockholders' equity................................................ $ (1,363,939) $ (1,610,987)
------------- -------------
Total liabilities and stockholders' equity................................ $ 1,537,273 $ 1,290,225
------------- -------------
------------- -------------
<CAPTION>
FOR THE YEAR ENDED
NOVEMBER 30, 1996
----------------------------
AS REPORTED PRO FORMA
------------- -------------
<S> <C> <C>
Total other income (expense).............................................. $ (185,884) $ (483,532)
------------- -------------
Loss before income taxes.................................................. $ (1,245,245) $ (1,542,893)
------------- -------------
Deferred income tax benefit............................................... $ 211,692 $ 262,292
------------- -------------
Net loss.................................................................. $ (1,033,553) $ (1,280,601)
------------- -------------
------------- -------------
Loss per common share..................................................... $ (1.34) $ (1.66)
------------- -------------
------------- -------------
</TABLE>
Subsequent to the Company's year end, $200,000 was advanced to an individual
who is its president and stockholder.
NOTE 17--EVENT SUBSEQUENT TO THE DATE OF THE REPORT OF INDEPENDENT CERTIFIED
PUBLIC ACCOUNTANTS
On February 7, 1997, the Company closed the corporate office and the retail
outlet that had opened in the first quarter of 1996. The Company may have a
contingent liability for leases of these premises up to a maximum amount of
$67,500. Management anticipates these actions will represent substantial savings
to the Company in the form of reduced operating costs.
16
<PAGE>
PART III
ITEM 10. DIRECTOR AND EXECUTIVE OFFICERS OF THE REGISTRANT.
DIRECTORS AND EXECUTIVE OFFICERS
The following table sets forth certain information concerning the directors
and executive officers of the Company.
<TABLE>
<CAPTION>
INITIAL DATE OF
NAME OFFICE AGE SERVICE
- -------------------------- --------------------------------------------- --- ----------------------
<S> <C> <C> <C>
John J. Pidorenko Chairman of the Board, President, Chief 55 August 12, 1993
Executive Officer
John R. Trusty Secretary, Treasurer, Chief Financial 41 January 13, 1995
Officer, Chief Accounting Officer, Director
Kendall B. Stiles, M.D. Director 40 April 4, 1996
Michael Hankins, Sr. Director 55 April 4, 1996
Darryl Riley Director 33 August 12, 1993
</TABLE>
Executive officers are elected by the Board of Directors and serve until
their successors are duly elected and qualify, subject to earlier removal by the
Board of Directors. Directors are elected at the annual meeting of shareholders
to serve for their term and until their respective successors are duly elected
and qualify, or until their earlier resignation, removal from office, or death.
The remaining directors may fill any vacancy in the Board of Directors for an
unexpired term. Directors serve for a one year term of office.
BUSINESS EXPERIENCE OF DIRECTORS AND EXECUTIVE OFFICERS
JOHN J. PIDORENKO is the founder of the Company and is currently its
Chairman of the Board, President and Chief Executive Officer. From 1990 through
August 1993, Mr. Pidorenko was an independent marketing consultant for
telemarketing strategies employed by large companies, such as Beneficial
Insurance. Mr. Pidorenko was employed as an Executive Vice President of
Fiberoptic Sensor Technologies according monitoring medical equipment
manufacturer for the years 1985 to 1989. Mr. Pidorenko was the founder, in 1983,
of Micro Technologies, which was sold to Fiberoptic Sensor Technologies in 1985.
JOHN R. TRUSTY has been the Company's Secretary and Chief Financial Officer
since January 1995. Prior to his employment with the Company, Mr. Trusty was a
Certified Public Accountant sole practitioner from July 1992 through December
1994. During 1994, Mr. Trusty was involved with the Company as an independent
consultant. From April 1986 through July 1992, Mr. Trusty served as Controller
for Westshore Glass Corp., a glass, mirror and aluminum storefront wholesaler.
KENDALL B. STILES, M.D. has been a director of the Company since April 4,
1996. Dr. Stiles has been employed as an emergency room physician for the last
five years in the State of Virginia and is the officer, director and sole
shareholder of American Medical Emergency Services, Inc. located in Virginia.
Dr. Stiles is the brother-in-law of John Pidorenko.
MICHAEL HANKINS, SR. has been a director of the Company since April 4, 1996.
Since 1990, Mr. Hankins has been the owner/operator of the Southern Hotel, which
is a historic inn located in Missouri. From 1978 through 1990, Mr. Hankins was a
lead project analyst for Ralston Purina Company.
DARRYL RILEY has been a director of the Company since August 12, 1993. For
the last five years, he has owned a general contracting company in the Central
Florida area.
17
<PAGE>
DIRECTOR COMPENSATION
A director who is an employee of the Company receives no additional
compensation for services as director or for attendance at or participation
in meetings. A director who is not an employee of the Company is paid $100
for each Board or Committee meeting which the director attends, in person or
otherwise. A director who is not an employee is also reimbursed for
out-of-pocket expenditures incurred in attending or otherwise participating
in meetings.
The Company currently has no other arrangements regarding compensation
for services as a director.
ITEM 11. COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS.
EXECUTIVE COMPENSATION
The following table shows the compensation paid or accrued by the Company
for the fiscal years ended November 30, 1996, 1995 and 1994, to or for the
account of the Chief Executive Officer. No other executive officer of the
Company received compensation in excess of $100,000 or more during the stated
periods. Accordingly, the summary compensation table does not include
compensation of other executive officers.
SUMMARY COMPENSATION TABLE
<TABLE>
<CAPTION>
RESTRICTED
OTHER ANNUAL STOCK OPTIONS/ LTIP
NAME AND SALARY BONUS COMPENSATION AWARD(S) SARS PAYOUTS
PRINCIPAL POSITION YEAR ($) ($) ($) ($) (#) ($)
- ------------------------------- --------- --------- --------- ------------- ----------- --------- ---------
<S> <C> <C> <C> <C> <C> <C> <C>
John Pidorenko(1) 1996 120,481 35,000 -- -- 500,000(2) --
President, Chief 1995 50,000 -- -- -- -- --
Executive Officer 1994 -0- -- -- -- -- --
<CAPTION>
ALL OTHER
NAME AND COMPENSATION (1)
PRINCIPAL POSITION ($)
- ------------------------------- ------------------
<S> <C>
John Pidorenko(1) $ 31,103
President, Chief 15,000
Executive Officer 12,500
</TABLE>
- ------------------------
(1) Represents the net amount due the Company for advances.
(2) See "Employment Agreements".
AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR AND FISCAL YEAR END OPTION
VALUES
There were no options which were exercised by any executive officers during
fiscal 1996. There are no further options which were granted to executive
officers which could have been exercised during fiscal 1996.
EMPLOYMENT AGREEMENTS
On April 4, 1996, Mr. Pidorenko entered into an Employment Agreement
with the Company, which provides for his employment as President and Chief
Executive Officer for five years. Under this Agreement, Mr. Pidorenko will
receive a base salary of $150,000. As an additional inducement for entering
into the Agreement, the Board of Directors awarded Mr. Pidorenko a $35,000
bonus. Mr. Pidorenko was also awarded options exercisable for five years
which entitle him to acquire up to 500,000 shares of the Company's Common
Stock at the initial public offering price of $4.00. Mr. Pidorenko has
agreed with the Underwriter to reduce his base salary from $150,000 to
$90,000 annually, effective upon the closing of this offering. Mr. Pidorenko
has also agreed that so long as any current shareholders are subject to a
"lock-up" agreement with the Underwriter, he shall not be paid a bonus or
granted a salary increase under his Employment Agreement.
The Compensation Committee will meet periodically, as the results of
each fiscal year are available, to consider awarding additional compensation
to Mr. Pidorenko above his salary. Mr. Pidorenko's employment agreement
contains a restrictive covenant not to compete for the term of the Agreement
and for two years following termination of service. The employment agreement
also provides for a car allowance and also requires the Company to indemnify
Mr. Pidorenko to the maximum extent provided under the laws of the State of
Florida. This Agreement provides for severance payments equal to 299% of
the annual base compensation, or a maximum of $270,000, due under this
agreement in the event there is a "change of control" of the Company, as
defined therein, and he is subsequently terminated without cause.
On April 4, 1996, Mr. Trusty entered into an Employment Agreement with
the Company, which provides for his employment as Chief Financial Officer for
a one year term. The Agreement is automatically renewable for an additional
one year period unless either party decides to terminate. Under the
Agreement, Mr. Trusty receives a base salary of $55,000 and was paid a
$10,000 bonus. If the Agreement is extended beyond one (1) year, Mr.
Trusty's salary increases 10% in each year. The Company and Mr. Trusty have
agreed to extend his employment agreement until April 1998. The Compensation
Committee will meet periodically, as the results of each fiscal year are
availabile, to consider awarding additional compensation to Mr. Trusty above
his salary. The Agreement contains a restrictive covenant not to compete for
the term of the Agreement and for two years following termination of service.
The Agreement provides for a car allowance and also requires the Company to
indemnify Mr. Trusty to the maximum extent provided under the laws of the
State of Florida. This Agreement also provides for severance payments equal
to 299% of the annual base compensation due under the Agreement in the event
there is a "change of control" of the Company, as defined therein, and he is
subsequently terminated without cause.
STOCK OPTION PLAN
The Company intends to adopt a stock option plan which will authorize
the grant of stock options under Section 422 of the Internal Revenue Code. A
total of 350,000 shares have been reserved for issuance under the plan. The
plan will provide that the exercise price of options granted under the plan
shall not be less than the fair market value of the shares on the date on
which the option is granted unless an employee, immediately before the grant
owns more then 10% of the total combined voting power of all classes of stock
of the Company or any subsidiaries, whereupon the exercise price shall be at
least 110% of the fair market value of the Shares on the date on which the
option is granted. The term of each option and the manner in which it may be
exercised is determined by the Board of Directors, or a committee appointed
by the Board of Directors, provided that no option may be exerciseable more
than 10 years after the date of grant, and, in the case of an incentive
option granted to an eligible employee owning more than 10% of the common
stock, no more than five years. Options may be granted to officers,
directors, employees, and consultants. In the event of death or disability,
options may be exercised during a twelve month period following such event.
In the event that an optionholder is terminated other than pursuant to death,
disability or retirement, all options must be exercised by the date of
termination. Options are not transferable, except upon death of optionee.
INDEMNIFICATION
The Company's Bylaws provide, in general, that the Company shall
indemnify its directors and officers under the circumstances specified under
applicable Florida law and gives authority to the Company to purchase
insurance with the respect to such indemnification.
Mr. Pidorenko and Mr. Trusty's employment agreements provide, among
other things, for: (i) indemnification by the Company of such individual to
the fullest extent permitted by law against any and all expenses, judgments,
fines and amounts paid in settlement of any claim against an indemnified
party (the "Indemnitee") unless it is determined that the indemnification is
not permitted under the law; and (ii) the prompt advancement of expenses to
any Indemnitee in connection with his defense against any threatened or
pending claim. Similar indemnification arrangements may from time to time be
entered into with additional officers of the Company or certain other
employees or agents of the Company. All directors of the Company are also
parties to indemnification agreements which provide for similar rights of
indemnification.
The Company has been advised that it is the position of the Commission
that insofar as the foregoing provision may be invoked to disclaim liability
for damages arising under the Securities Act, that such provisions are
against public policy as expressed in the Securities Act and are therefore
unenforceable.
18
<PAGE>
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.
The following table sets forth information concerning the beneficial
ownership as of February 15, 1997, of the Company's Common Stock by the
directors and executive officers, individually and as a group. The table also
sets forth the only persons who, to the Company's knowledge, are the beneficial
owners of more than five (5%) percent of the outstanding voting securities of
the Company. Each person has sole voting and investment power with respect to
the shares reported, except as otherwise noted. The address of each individual
is in care of the Company.
<TABLE>
<CAPTION>
NUMBER OF SHARES
BENEFICIALLY OWNED PERCENT OWNED (2)(8)
BEFORE -------------------------------------
NAME OF BENEFICIAL OWNER OFFERING (1)(7) BEFORE OFFERING AFTER OFFERING
- ----------------------------------------------------------------- -------------------- ------------------- ----------------
<S> <C> <C> <C>
John Pidorenko (3)(4)............................................ 916,067 63% 18.9%
John R. Trusty (3)............................................... 20,000 1% 1%
Michael Hankins, Sr. (5)......................................... 0 --% --%
Kendall B. Stiles, M.D. (6)...................................... 71,542 5% 2.5%
Darryl Riley (3)(7).............................................. 93,877 6% 3.3%
All Directors and Officers (as a group).......................... 1,101,486 76% 38.9%
</TABLE>
- ------------------------
(1) The amount and percentage of securities beneficially owned by an individual
are determined in accordance with the definition of beneficial ownership set
forth in the regulations of the Securities and Exchange Commission to the
Securities Exchange Act of 1934 and, accordingly, may include securities
owned by or for the spouse and/or minor children of the individual and any
other relative who has the same home as an individual, as well as other
securities as to which the individual has shares voting or investment power
or has the right to acquire within 60 days of the date of this Prospectus.
Beneficial ownership may be disclaimed as to certain of the securities.
Unless otherwise indicated, all shares listed are owned both of record and
beneficially.
(2) Based upon 1,285,171 shares of Common Stock issued and outstanding as of
March 12, 1997, and securities not outstanding which are subject to such
options, warrants, rights or conversion privileges shall be deemed to be
outstanding for the purpose of computing the percentage of outstanding
securities of the class owned by such person but shall not be deemed to be
outstanding for the purpose of computing the percentage of the class by any
other person.
(3) May be deemed to be a "founder" of the Company for the purpose of the
Securities Act of 1933, as amended.
(4) 416,067 shares of the Company's Common Stock currently held by Mr. Pidorenko
are being registered under the Securities Act as part of this Prospectus.
The above amount also includes options to acquire up to 500,000 shares
granted to Mr. Pidorenko in connection with his employment agreement
exercisable at $4.00 for 5 years. If the options are excluded, Mr. Pidorenko
currently owns approximately 23% of the outstanding shares of Common Stock
and would own approximately 16% of the outstanding shares of Common Stock
upon the closing of the offering. The above amount excludes 5,000,000 shares
of Voting Preferred Stock held by Mr. Pidorenko. Each share of Voting
Preferred Stock is entitled to a one-half ( 1/2) vote. Upon the closing of
this offering, and assuming the 416,067 shares of Common Stock currently
held by Mr. Pidorenko are sold, he would control 45% of the voting equity
securities of the Company through the voting Preferred Stock.
(5) As of March 7, 1997, Mr. Hankins and his son, who hold $225,000 of
convertible promissory notes, plus accrued interest thereon have not
converted such notes. Mr. Pidorenko has agreed to assume the obligations
under these notes.
(6) Includes 58,252 shares of Common Stock issued in exchange for cancelling a
$100,000 convertible note, plus accrued interest thereon. Dr. Stiles is the
brother-in-law of Mr. Pidorenko. See "Certain Transactions."
(7) Includes 37,282 shares of Common Stock issued in exchange for cancelling
$60,000 of a $100,000 convertible note, plus accrued interest thereon.
(8) Excludes (i) the Warrants, (ii) the Underwriter's Warrants and
Over-Allotment Option and, (iii) 350,000 shares reserved for issuance under
the Company's 1996 Stock Option Plan. Also reflects the conversion of
$598,500 convertible notes, plus accrued interest into 373,803 shares of
Common Stock.
19
<PAGE>
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.
In September 1995, the Company commenced a private placement offering of
securities in the form of convertible notes in order to obtain funds to be used
for working capital, to pay operating expenses, to acquire a complementary paint
company or equipment necessary to manufacture the Company's insulative coatings,
and to pay the organizational and underwriting costs to be incurred in an
initial public offering of the Company's stock. A second offering of unsecured
notes and common stock was commenced January 1996 to obtain additional funds for
the purposes stated above. The selling agents received up to ten percent (10%)
of the amounts raised.
Included in notes payable at November 30, 1995 and 1996 are $740,203 and
$1,898,500, respectively, representing the aggregate amount raised by the
Company in various debt related offering as of those dates. The notes bear
interest at the rate of twelve percent (12%), with principal and interest due on
the earlier of the date of the closing of the public offering or one year from
the date of the notes. The notes were convertible, at the option of the holder,
to an amount of common stock based between 50% to 60% of the price of the shares
of the Company's common stock to be offered in the public offering. The option
to convert was conditioned upon the closing of the initial public offering of
the Company's stock. Because the closing did not occur, the notes are payable at
the original one year maturity date. At November 30, 1996, $505,000 of these
notes were in default.
As a condition to the public offering, the holders of $598,500 of these
notes payable agreed to convert such notes plus accrued interest thereon into
an aggregate of 373,803 shares of Common Stock. 299,250 shares were issued in
exchange for a principal debt reduction of $598,500 and 74,553 shares of
Common Stock were issued to satisfy approximately $149,106 of accrued
interest due on all outstanding notes. Dr. Stiles, and Mr. Riley, each of
whom are directors of the Company converted $100,000 and $40,000 notes
respectively, plus accrued interest thereon into 16,504 and 34,564 shares of
the Company's Common Stock as part of this exchange Mr. Hankins and his son
loaned the Company an aggregate of $225,000 plus accrued interest which debt
has been personally assumed by Mr. Pidorenko and is not being converted into
Common Stock. The Company does not expect that Mr. Hankins will be
reappointed to the board of directors. In connection with the conversion,
such holders have agreed not to sell their shares for a period of at least
two (2) years from the date of this Prospectus, without the Underwriter's
consent. The Underwriter has the right to extend this lock-up period for one
(1) additional year if the Company does not achieve during any 12 consecutive
month period a cumulative pre-tax profit on income, calculated in accordance
with GAAP of at least $3,000,000. The holders of approximately $960,000 of
obligations under various notes described were paid off in cash at the
closing of the public offering.
On February 17, 1997, the Company entred into a settlement agreement with
Consolidated Financial Management, Inc. ("Consolidated"). Consolidated was a
maker of a certain promissory note in the principal amount of $200,000 payable
to the Company, which was secured by 60,000 shares of Meadow Valley Corporation
common stock. Consolidated is the current holder of $300,000 face amount of
notes issued by the Company in favor of two bridge investors, who subsequently
assigned their notes to Consolidated. The Company was in default under its notes
due to the investors now held by Consolidated. Consolidated was in default under
its $200,000 note due to the Company, which is secured by the Meadow Valley
Corporation shares.
On February 13, 1997, Consolidated obtained a temporary restraining order in
the Superior Court, State of Arizona in and for the County of Mariposa which
prohibits ThermaCell from selling the Meadow Valley Corporation shares. The
settlement agreement provides that ThermaCell will release the Meadow Valley
Corporation shares to Consolidated upon ThermaCell receiving $100,000 from
Consolidated. The parties consummated this part of the settlement agreement.
ThermaCell is obligated to pay Consolidated upon the earlier of the closing of
this offering or 90 days the remaining sum of $258,789.01. The parties have
executed mutual releases and made appropriate representations in connection with
this settlement agreement.
20
<PAGE>
To induce certain stockholders to enter into the Lock-Up arrangements
required by the Underwriter, the Company issued approximately 318,150 shares of
Common Stock so that such stockholders would have a $2.00 cost basis in their
shares of Common Stock, which is the same cost basis offered to the converting
noteholders.
John Pidorenko has agreed to personally assume and indemnify the Company
against approximately $660,000 of principal and accrued interest obligations
under certain of the Company's outstanding promissory notes. Mr. Pidorenko
agreed to assign his interest in the proceeds from the sale of his shares of
Common Stock registered under the Prospectus for the public offering to
secure this undertaking to repay this debt on the Company's behalf. As part
of this arrangement, the Company is in the final stages of negotiating an
agreement with an unaffiliated individual regarding the payment of $300,000
of the Company's promissory notes and $75,000 this individual loaned another
entity, a portion of the proceeds of which were made available to the
Company. The amounts set forth in the Prospectus assume the Company will pay
$100,000, plus accrued interest, of the $300,000 currently due this investor
from offering proceeds. The remaining $200,000 loaned to the Company and the
$75,000 loaned to the other entity, plus accrued interest thereon is being
assumed by Mr. Pidorenko. Under the proposed arrangement the Company would
escrow $300,000 of offering proceeds which would be paid to this investor if
Mr. Pidorenko does not satisfy this assumed obligation before May 15, 1997.
In such event, the Company would have an interest in the proceeds from the
sale of Mr. Pidorenko's shares which were registered as part of the public
offering to satisfy this payment on Mr. Pidorenko's behalf. As part of this
agreement, the investor would be issued 125,000 restricted units which would
be identical to the Units offered to the public in the public offering and
the investor would enter into a two year lock-up arrangement.
Through all private placements of the notes described above, Company relied
upon exemptions from registration under the Securities Act pursuant to Sections
3(b) and 4(2) and Regulation D promulgated thereunder. Of the 55 investors, 40
represented to the Company that they were "accredited" as that term is defined
under Regulation D. All purchasers represented, in a manner satisfactory to the
Company, that they were sophisticated and otherwise understood the risks
associated with the offering.
In connection with the formation of the Company, Mr. Pidorenko received
416,067 shares of Common Stock and 5,000,000 shares of Preferred Stock. The
Preferred Stock has one-half vote per share on all matters submitted to the vote
of the holders of Common Stock, but did not originally have any conversion
rights. The voting Preferred Stock was entitled to one vote per share but was
reduced by one-half vote per share.
In order to provide Mr. Pidorenko a long-term financial incentive for the
Company's success, Mr. Pidorenko has the option to convert all or part of his
Voting Preferred Stock into shares of the Company's Common Stock. To the extent
the Company has generated at least one fiscal quarter of positive net income
during any subsequent fiscal year after this offering, Mr. Pidorenko would be
entitled to convert up to one half (1/2) of his shares of Voting Preferred Stock
into shares of Common Stock at a conversion ratio of four shares of Voting
Preferred Stock for one share of Common Stock, or up to 625,000 shares of Common
Stock. The other half of Mr. Pidorenko's Voting Preferred Stock is convertible
into an additional 625,000 shares of Common Stock at the same conversion ratio
provided that the Company generates at least one complete fiscal year with
positive net income. The issuance of the Voting Preferred Stock to Mr. Pidorenko
constitutes an anti-takeover device.
Mr. Pidorenko also entered into an employment agreement with the Company
that provided for a $35,000 cash payment upon execution, which he has deferred,
and the issuance of options to acquire up to 500,000 shares of the Company's
Common Stock at the public offering price of $4.00 per share for a five year
period. John R. Trusty, the Company's Chief Financial Officer, owns 20,000
shares of the Company's Common Stock which he received as nominal consideration
for his services to the Company at a salary below market levels. Mr. Trusty
received a $10,000 bonus upon execution of his employment agreement which
provides for a minimum annual base salary of $55,000.
21
<PAGE>
From time to time Mr. Pidorenko has advanced funds to the Company and the
Company has advanced funds to Mr. Pidorenko. During the year ended November 30,
1996, the Company advanced Mr. Pidorenko $31,103 in excess of funds he advanced
to the Company. At November 30, 1996, the net amount payable by the Company to
Mr. Pidorenko was $5,723. Mr. Pidorenko also agreed to defer his $35,000 bonus
due upon execution of his Employment Agreement and a portion of his base salary.
As of February 15, 1997, Mr. Pidorenko owed the Company approximately $47,000.
Mr. Pidorenko has agreed to defer portions of his monthly salary over the next
year to repay these advances. Mr. Pidorenko's daughter and son-in-law are
employed by the Company in administrative and clerical functions. The Company
paid these individuals approximately $37,000 in fiscal 1996. These individuals
do not have employment agreements.
The Company believes that all transactions with officers, directors or
affiliates to date are on terms no less favorable than those available from
unaffiliated third parties. Although no other transactions were contemplated, it
is the Company's policy that all future transactions with its officers,
directors or affiliates will be approved by the independent members of the
Company's Board of Directors not having an interest in the transaction and will
be on terms no less favorable than could be obtained from unaffiliated third
parties.
22
<PAGE>
PART IV
ITEM 14. EXHIBITS, FINANCIAL STATEMENTS, SCHEDULES AND REPORTS ON FORM 8-K.
(a)(1)(2) FINANCIAL STATEMENTS AND FINANCIAL STATEMENT SCHEDULES.
A list of the Financial Statements filed as part of this Report is set
forth in Item 8 and appears at Page F-1 of this Report; which list is
incorporated herein by reference. The Financial Statement Schedules and the
Report of Independent Auditors as to Schedules follow the Exhibits.
(a)(3) EXHIBITS.
SEQUENTIALLY
EXHIBIT NUMBERED
NO. DESCRIPTION PAGE
- ------- ----------- ------------
1.1 Revised Form of Underwriting Agreement*
1.2 Revised Form of Underwriter's Warrants*
1.3 Revised Form of Selected Dealers Agreement*
1.4 [Reserved]
1.5 [Reserved]
1.6 Executed Escrow Agreement and Amendment thereto entered
into by First of America, Bank of Michigan, N.A., the
Company and the Underwriters*
3.1 Certificate of Incorporation and Amendment to Certificate
of Incorporation of the Company*
3.1(a) Certificate of Amendment to Certificate of Incorporation to
reflect 1 for 10 reverse stock split*
3.1(b) Form of Certificate of Amendment to Certificate of Rights,
Designation and Preferences of Series A Preferred Stock*
3.2 Bylaws of the Company*
3.3 Amendment to Bylaws*
4.1 Specimen of Common Stock Certificate*
4.2 Specimen of Warrant Certificate*
4.3 Revised Form of Warrant Agreement*
4.4 Conversion Notice and Election Form for Convertible Note Holder*
5.1 Opinion of Johnson, Blakely, Pope, Bokor, Ruppel & Burns,
P.A. as to legality of issuance of Units*
10 Employment Agreement (4/4/96) John Pidorenko*
10(A) Employment Agreement (4/4/96) John Trusty*
10(B) Form of Convertible Note*
10(C) Trademark Registration for ThermaCool-TM-*
23
<PAGE>
10(D) Published International Patent Application*
10(E) Stock Option Plan*
10(F) Asset Purchase Agreement for Darling Paint and Coatings
effective November, 1995*
10(G) Lease for Executive Offices*
10(H) Lease for Darling Paint*
10(I) Lease for Sarasota Store*
10(J) Promissory Note (3/6/96)*
23.1 Consent of Cherry, Bekaert & Holland, C.P.A.'s, Clearwater,
Florida*
23.2 Consent of Johnson, Blakely, Pope, Bokor, Ruppel & Burns,
P.A., Clearwater, Florida (included in its opinion filed as
Exhibit 5.1)*
- ------------------------
* Previously filed under cover of Form SB-2 (SEC File No. 333-22001).
24
<PAGE>
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
Date: April 10, 1997 By: /s/ JOHN PIDORENKO
------------------------------------
John Pidorenko
Pursuant to the requirements of the Securities Exchange Act of 1934, this
report has been signed below by the following persons on behalf of the
Registrant and in the capacities and on the dates indicated.
SIGNATURE TITLE DATE
--------- ----- ----
/s/ JOHN PIDORENKO President and Chief Executive
- --------------------------- Officer (Principal Executive April 10, 1997
John Pidorenko Officer) and Chairman of
the Board
/s/ JOHN TRUSTY Vice President and Chief
- --------------------------- Financial Officer (Principal April 10, 1997
John Trusty Financial Officer) and Principal
Accounting Officer
/s/ KENDALL B. STILES M.D.
- --------------------------- Director April 10, 1997
Kendall B. Stiles M.D.
- --------------------------- Director April __, 1997
Michael Hankins, Sr.
/s/ DARRYL RILEY
- --------------------------- Director April 10, 1997
Darryl Riley
<PAGE>
[LOGO]
April 10, 1997
Board of Directors
ThermaCell Techologies, Inc.
We consent to the use of our report dated January 15, 1997, on the financial
statements of ThermaCell Technologies, Inc. in Form 10-KSB for the year ended
November 30, 1996.
Cherry, Bekaert & Holland, L.L.P.
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> YEAR
<FISCAL-YEAR-END> NOV-30-1996
<PERIOD-START> DEC-01-1995
<PERIOD-END> NOV-30-1996
<CASH> 18,512
<SECURITIES> 0
<RECEIVABLES> 85,006
<ALLOWANCES> 21,000
<INVENTORY> 150,872
<CURRENT-ASSETS> 456,795
<PP&E> 322,979
<DEPRECIATION> 41,060
<TOTAL-ASSETS> 1,537,273
<CURRENT-LIABILITIES> 2,901,212
<BONDS> 0
0
500
<COMMON> 87
<OTHER-SE> (1,364,526)
<TOTAL-LIABILITY-AND-EQUITY> 1,537,273
<SALES> 615,845
<TOTAL-REVENUES> 615,845
<CGS> 394,867
<TOTAL-COSTS> 1,675,206
<OTHER-EXPENSES> 210,647
<LOSS-PROVISION> 10,000
<INTEREST-EXPENSE> 207,147
<INCOME-PRETAX> (1,245,245)
<INCOME-TAX> (211,692)
<INCOME-CONTINUING> (1,033,553)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,033,553)
<EPS-PRIMARY> (1.34)
<EPS-DILUTED> (1.34)
</TABLE>
